See also this year's filing and all EDGAR filings for this company.
PDF Report 0000318306_2013_Abeona_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Liabilities', 'value': 15392000, 'size_variable': 'Assets', 'size_value': 613000, 'ratio': 25.1, 'threshold': 20} |
Graph
Absolute values for 0000318306, Abeona Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,681,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,000 |
| 3 | remainder_Assets | 42,000 |
| 4 | LiabilitiesCurrent | 6,629,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 12,177,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,024,000 |
| 9 | ResearchAndDevelopmentExpense | 2,010,000 |
| 10 | remainder_Expenses | 686,000 |
| 11 | remainder_Revenues | 4,404,000 |
| 12 | remainder_NetIncome | -6,216,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,730,000 |
| 1 | Liabilities | 18,806,000 |
| 2 | Expenses | 8,720,000 |
| 3 | Revenues | 4,404,000 |
| 4 | StockholdersEquity | -17,076,000 |
| 5 | NetIncome | -10,532,000 |
| 6 | ComprehensiveNetIncome | -10,532,000 |
| 7 | BaseVar | 19,938,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.65 |
| 9 | EconomicCapitalRatio | 0.250 |
Edgar->Model Mapping
Feature Distribution
Change over Time
